Since 1938, animal testing has been required by the FDA before any new drug can proceed through clinical trials and receive ...

The top-line results of the APOLLOE4 trial showed that valitramiprosate (ALZ-801) was unable to slow down cognitive decline ...

Novartis has announced a massive investment in manufacturing and R&D facilities in the US, including seven new facilities, in ...

Top NHS doctor, CEO out. Across the pond, NHS England is also seeing big changes with Sir Stephen Powis announcing his plans ...

The EMA has called a temporary halt to a phase 2 trial of Sarepta's Roche-partnered Duchenne muscular dystrophy (DMD) gene ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access ...

A notice posted by the NIH in February said the agency would slash its funding of indirect costs borne by research teams at ...

AKT inhibitor Truqap (capivasertib) has been cleared by NICE for use in combination with standard therapy fulvestrant for ...

Incyte's infringement lawsuit is claiming that Sun Pharma's drug infringes a US patent (No. 9,662,335) it holds on the use of ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...